Sovereign Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$756K Sell
13,116
-425
-3% -$24.4K 0.12% 163
2026
Q1
$821K Buy
13,541
+674
+5% +$39.3K 0.14% 134
2025
Q4
$694K Buy
12,867
+236
+2% +$11.4K 0.12% 150
2025
Q3
$570K Sell
12,631
-439
-3% -$20.5K 0.11% 167
2025
Q2
$605K Sell
13,070
-718
-5% -$35.2K 0.12% 147
2025
Q1
$841K Sell
13,788
-434
-3% -$25.3K 0.19% 102
2024
Q4
$804K Sell
14,222
-595
-4% -$33.2K 0.18% 109
2024
Q3
$767K Sell
14,817
-95
-0.6% -$4.46K 0.18% 111
2024
Q2
$619K Buy
14,912
+1,241
+9% +$55.5K 0.15% 121
2024
Q1
$741K Buy
13,671
+455
+3% +$23.2K 0.2% 104
2023
Q4
$678K Sell
13,216
-950
-7% -$49.9K 0.21% 92
2023
Q3
$822K Sell
14,166
-1,379
-9% -$84.5K 0.29% 72
2023
Q2
$994K Buy
15,545
+916
+6% +$61.4K 0.32% 76
2023
Q1
$1.01M Buy
14,629
+1,262
+9% +$89K 0.38% 69
2022
Q4
$962K Buy
13,367
+1,457
+12% +$110K 0.38% 69
2022
Q3
$847K Sell
11,910
-39
-0.3% -$2.83K 0.34% 72
2022
Q2
$920K Sell
11,949
-84
-0.7% -$6.4K 0.36% 72
2022
Q1
$879K Buy
12,033
+1,078
+10% +$72.4K 0.33% 78
2021
Q4
$683K Buy
10,955
+77
+0.7% +$4.52K 0.27% 97
2021
Q3
$644K Sell
10,878
-299
-3% -$19.7K 0.37% 61
2021
Q2
$706K Hold
11,177
0.43% 52
2021
Q1
$706K Buy
11,177
+984
+10% +$61.2K 0.44% 50
2020
Q4
$632K Buy
+10,193
New +$627K 0.46% 53

Other funds holding BMY

Sovereign Financial Group's BMY Position: Q2 2026 in Review

Sovereign Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 3.1% in Q2 2026, selling an estimated $24.4K and leaving 13,116 shares worth $756K. The position accounts for 0.12% of the portfolio, ranked #163.

Sovereign Financial Group first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q1 2023. 945 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sovereign Financial Group held 13,116 shares of Bristol-Myers Squibb worth $756K as of Q2 2026.
  • Sovereign Financial Group sold 425 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.4K.
  • Bristol-Myers Squibb made up 0.12% of Sovereign Financial Group's portfolio in Q2 2026, its #163 holding.
  • Sovereign Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Sovereign Financial Group's Bristol-Myers Squibb position peaked at $1.01M in Q1 2023.
  • 945 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sovereign Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.